Henrik NILSSON,Florian SCHÖNHARTING,Bernd W. MÜLLER,Joseph R. ROBINSON
申请号：
US13957220
公开号：
US20130316003A1
申请日:
2013.08.01
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention features a method of treating a subject in need of treatment for multiple sclerosis. The method involves orally administering to the subject in need thereof a pharmaceutical composition in unit dosage form consisting essentially of (a) from about 120 mg to about 240 mg of dimethylfumarate formulated for delayed release, and (b) one or more pharmaceutically acceptable excipients, wherein following the orally administering of the unit dosage form monomethylfumarate appears in the plasma of the subject upon hydrolysis of dimethylfumarate and the Cmax of the monomethylfumarate in the plasma of the subject is between about 0.4 and about 2 mg/L, and wherein about 480 mg of dimethylfumarate per day is orally administered to the subject.
